Impact of direct disk-diffusion testing on time to optimal antibiotic therapy

Tulip A. Jhaveri; Ahmad Taqi; Jeffrey C. Pearson; Sanjat Kanjilal

doi:10.1017/ash.2023.128

Antimicrobial Stewardship & Healthcare Epidemiology (Jan 2023)

Impact of direct disk-diffusion testing on time to optimal antibiotic therapy

Tulip A. Jhaveri,
Ahmad Taqi,
Jeffrey C. Pearson,
Sanjat Kanjilal

Affiliations

Tulip A. Jhaveri: ORCiD; Division of Infectious Diseases, Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi Division of Medical Microbiology, Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts
Ahmad Taqi: Department of Pharmacy, Brigham and Women’s Hospital, Boston, Massachusetts Department of Pharmacy Practice, Faculty of Pharmacy, Kuwait University, Kuwait
Jeffrey C. Pearson: Department of Pharmacy, Brigham and Women’s Hospital, Boston, Massachusetts
Sanjat Kanjilal: ORCiD; Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Healthcare Institute, Boston, Massachusetts Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, Massachusetts

DOI: https://doi.org/10.1017/ash.2023.128
Journal volume & issue: Vol. 3

Abstract

Read online

We evaluated the impact of preliminary blood-culture antibiotic susceptibility testing on time to optimal antibiotic therapy in a cohort of 503 patients with monomicrobial bloodstream infections. The median time from blood-culture collection to optimal antibiotics was 17 hours earlier in the preliminary antibiotic susceptibility testing group.

Published in Antimicrobial Stewardship & Healthcare Epidemiology

ISSN: 2732-494X (Online)
Publisher: Cambridge University Press
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Infectious and parasitic diseases; Medicine: Public aspects of medicine
Website: https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology

About the journal